Detalhe da pesquisa
1.
Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [18F]BCPP-EF PET study.
EJNMMI Res;
14(1): 41, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38632153
2.
Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.
Mol Imaging Biol;
2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570447
3.
Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A.
Biol Psychiatry;
95(7): 639-646, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37330164
4.
Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.
Mol Imaging Biol;
25(6): 1054-1062, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37872462
5.
Time to re-evaluate the risks and benefits of valproate and a call for action.
Br J Psychiatry;
221(6): 711-713, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35795925
6.
Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study.
Psychopharmacology (Berl);
239(11): 3439-3445, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34175983
7.
Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.
Mol Imaging;
2022: 4419221, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721730
8.
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study.
Transl Psychiatry;
11(1): 393, 2021 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282130
9.
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse.
Schizophr Bull;
47(4): 1116-1129, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33754644
10.
Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortex.
Behav Brain Res;
405: 113203, 2021 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33636238
11.
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine.
Mol Psychiatry;
26(6): 2562-2576, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32382134
12.
The magnitude and heterogeneity of antidepressant response in depression: A meta-analysis of over 45,000 patients.
J Affect Disord;
276: 991-1000, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32750615
13.
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.
Nat Commun;
11(1): 246, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31937764
14.
Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology.
Neuropharmacology;
172: 107704, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31299229
15.
Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis.
Lancet Psychiatry;
7(1): 64-77, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31860457
16.
The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study.
Biol Psychiatry;
85(1): 79-87, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30122287
17.
Effects of chronic antipsychotic drug exposure on the expression of Translocator Protein and inflammatory markers in rat adipose tissue.
Psychoneuroendocrinology;
95: 28-33, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29793094
18.
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
Br J Psychiatry;
209(5): 361-365, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802977
19.
Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers.
J Neurol Sci;
368: 243-8, 2016 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27538642
20.
Phosphodiesterase 10A in Schizophrenia: A PET Study Using [(11)C]IMA107.
Am J Psychiatry;
173(7): 714-21, 2016 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26892941